Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Dendritic Cell-Based Tumor Vaccines and Antigen Presentation AttenuatorsMolecular therapy, 2006-05, Vol.13 (5), p.850-858 [Peer Reviewed Journal]2006 ;Copyright Nature Publishing Group May 2006 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2006.02.009 ;PMID: 16574490Full text available |
|
2 |
Material Type: Article
|
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?Molecular therapy, 2020-11, Vol.28 (11), p.2320-2339 [Peer Reviewed Journal]2020 The American Society of Gene and Cell Therapy ;Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2020 The American Society of Gene and Cell Therapy. 2020 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.09.015 ;PMID: 32979309Full text available |
|
3 |
Material Type: Article
|
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic DrugMolecular therapy, 2020-08, Vol.28 (8), p.1759-1771 [Peer Reviewed Journal]2020 The American Society of Gene and Cell Therapy ;Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2020 The American Society of Gene and Cell Therapy. 2020 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.06.015 ;PMID: 32592692Full text available |
|
4 |
Material Type: Article
|
A versatile platform for generating engineered extracellular vesicles with defined therapeutic propertiesMolecular therapy, 2021-05, Vol.29 (5), p.1729-1743 [Peer Reviewed Journal]2021 Codiak BioSciences, Inc. ;Copyright © 2021 Codiak BioSciences, Inc. Published by Elsevier Inc. All rights reserved. ;2021 Codiak BioSciences, Inc. 2021 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2021.01.020 ;PMID: 33484965Full text available |
|
5 |
Material Type: Article
|
Current Clinical Applications of In Vivo Gene Therapy with AAVsMolecular therapy, 2021-02, Vol.29 (2), p.464-488 [Peer Reviewed Journal]2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020 The Authors 2020 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.12.007 ;PMID: 33309881Full text available |
|
6 |
Material Type: Article
|
Revisiting the role of CD4 + T cells in cancer immunotherapy-new insights into old paradigmsCancer gene therapy, 2021-02, Vol.28 (1-2), p.5-17 [Peer Reviewed Journal]The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0929-1903 ;EISSN: 1476-5500 ;DOI: 10.1038/s41417-020-0183-x ;PMID: 32457487Full text available |
|
7 |
Material Type: Article
|
xCT: A Critical Molecule That Links Cancer Metabolism to Redox SignalingMolecular therapy, 2020-11, Vol.28 (11), p.2358-2366 [Peer Reviewed Journal]2020 The American Society of Gene and Cell Therapy ;Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2020 The American Society of Gene and Cell Therapy. 2020 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.08.021 ;PMID: 32931751Full text available |
|
8 |
Material Type: Article
|
Role of exosomal non-coding RNAs from tumor cells and tumor-associated macrophages in the tumor microenvironmentMolecular therapy, 2022-10, Vol.30 (10), p.3133-3154 [Peer Reviewed Journal]2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022 The Authors 2022 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2022.01.046 ;PMID: 35405312Full text available |
|
9 |
Material Type: Article
|
Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular MyopathyHuman gene therapy, 2020-07, Vol.31 (13-14), p.695-696 [Peer Reviewed Journal]Copyright Mary Ann Liebert, Inc. Jul 2020 ;ISSN: 1043-0342 ;EISSN: 1557-7422 ;DOI: 10.1089/hum.2020.182 ;PMID: 32605399Full text available |
|
10 |
Material Type: Article
|
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19Molecular therapy, 2021-07, Vol.29 (7), p.2219-2226 [Peer Reviewed Journal]2021 The Author(s) ;Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved. ;2021 The Author(s) 2021 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2021.05.004 ;PMID: 33992805Full text available |
|
11 |
Material Type: Article
|
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclatureCytotherapy (Oxford, England), 2019-10, Vol.21 (10), p.1019-1024 [Peer Reviewed Journal]2019 International Society for Cell and Gene Therapy ;Copyright © 2019 International Society for Cell and Gene Therapy. Published by Elsevier Inc. All rights reserved. ;ISSN: 1465-3249 ;ISSN: 1477-2566 ;EISSN: 1477-2566 ;DOI: 10.1016/j.jcyt.2019.08.002 ;PMID: 31526643Full text available |
|
12 |
Material Type: Article
|
Immune Responses to Viral Gene Therapy VectorsMolecular therapy, 2020-03, Vol.28 (3), p.709-722 [Peer Reviewed Journal]2020 The Author(s) ;Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved. ;2020 The Author(s) 2020 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.01.001 ;PMID: 31968213Full text available |
|
13 |
Material Type: Article
|
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPsMolecular therapy, 2021-11, Vol.29 (11), p.3293-3304 [Peer Reviewed Journal]2021 The Authors ;2021 The Authors 2021 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2021.06.004 ;PMID: 34091054Full text available |
|
14 |
Material Type: Article
|
Key chemokines direct migration of immune cells in solid tumorsCancer gene therapy, 2022-01, Vol.29 (1), p.10-21 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0929-1903 ;EISSN: 1476-5500 ;DOI: 10.1038/s41417-021-00303-x ;PMID: 33603130Full text available |
|
15 |
Material Type: Article
|
METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m6A Methylation in Oral Squamous Cell CarcinomaMolecular therapy, 2020-10, Vol.28 (10), p.2177-2190 [Peer Reviewed Journal]2020 The Author(s) ;2020 The Author(s) 2020 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2020.06.024 ;PMID: 32621798Full text available |
|
16 |
Material Type: Article
|
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic ApplicationsMolecular therapy, 2015-05, Vol.23 (5), p.812-823 [Peer Reviewed Journal]2015 American Society of Gene & Cell Therapy ;Copyright Nature Publishing Group May 2015 ;Copyright © 2015 American Society of Gene & Cell Therapy 2015 American Society of Gene & Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1038/mt.2015.44 ;PMID: 25868399Full text available |
|
17 |
Material Type: Article
|
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast CancerMolecular therapy, 2019-09, Vol.27 (9), p.1638-1652 [Peer Reviewed Journal]2019 The American Society of Gene and Cell Therapy ;Copyright © 2019 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. ;2019. The American Society of Gene and Cell Therapy ;2019 The American Society of Gene and Cell Therapy. 2019 The American Society of Gene and Cell Therapy ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2019.05.011 ;PMID: 31153828Full text available |
|
18 |
Material Type: Article
|
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA DeliveryMolecular therapy, 2019-04, Vol.27 (4), p.710-728 [Peer Reviewed Journal]2019 ;Copyright © 2019. Published by Elsevier Inc. ;Copyright Elsevier Limited Apr 10, 2019 ;2019. 2019 ;ISSN: 1525-0016 ;EISSN: 1525-0024 ;DOI: 10.1016/j.ymthe.2019.02.012 ;PMID: 30846391Full text available |
|
19 |
Material Type: Article
|
Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesiclesCytotherapy (Oxford, England), 2021-05, Vol.23 (5), p.373-380 [Peer Reviewed Journal]2021 International Society for Cell & Gene Therapy ;Copyright © 2021 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved. ;ISSN: 1465-3249 ;EISSN: 1477-2566 ;DOI: 10.1016/j.jcyt.2021.01.001 ;PMID: 33934807Full text available |
|
20 |
Material Type: Article
|
Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMNHuman gene therapy, 2018-03, Vol.29 (3), p.285-298 [Peer Reviewed Journal](©) Copyright 2018, Mary Ann Liebert, Inc. ;Copyright 2018, Mary Ann Liebert, Inc. 2018 ;ISSN: 1043-0342 ;EISSN: 1557-7422 ;DOI: 10.1089/hum.2018.015 ;PMID: 29378426Full text available |